STRO vs MSFT: Which Stock is Better?
Side-by-side comparison of Sutro Biopharma and Microsoft Corporation in 2026
STRO
Sutro Biopharma
$20.81
MSFT
Microsoft Corporation
$499.32
Key Metrics Comparison
| Metric | STRO | MSFT | Winner |
|---|---|---|---|
| Market Cap | $470.77M | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | MSFT |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 0.0% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze STRO
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is STRO or MSFT a better investment?
Comparing STRO and MSFT: Sutro Biopharma has a market cap of $470.77M while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between STRO and MSFT?
STRO (Sutro Biopharma) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: STRO or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: STRO or MSFT?
MSFT has higher revenue growth at 18.4% vs 0.0% for STRO.
Which company is more profitable: STRO or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for STRO.
Which is the larger company: STRO or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $470.77M for STRO.
Should I buy STRO or MSFT in 2026?
Both STRO and MSFT have investment merit. STRO trades at $20.81 while MSFT trades at $499.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between STRO and MSFT stock?
Key differences: Market Cap ($470.77M vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (0.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy STRO or MSFT in 2026?
The choice between STRO and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between STRO and MSFT?
STRO (Sutro Biopharma) has a market cap of $470.77M, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.